ERS 2016 Conference Review - Focus on Asthma, reviewed by Prof Peter Wark

In this Review:

Benralizumab (anti-IL5 receptor antagonist) in severe asthma
Lebrikizumab in severe asthma
Dupilumab and severe asthma, analysis by serum periostin
Reslizumab in uncontrolled eosinophilic asthma
DPP-4 inhibitors in experimental asthma
Long-term follow-up following BT
Allergen immunotherapy and asthma in children
Cluster analysis on longitudinal data of adult-onset asthma
Vitamin D supplementation and risk of asthma exacerbation

Please login below to download this issue (PDF)